Chronic antiplatelet therapy is not associated.pdf

Maryse A. Wiewel Sacha F. de Stoppelaar Lonneke A. van Vught Jos F. Frencken Arie J. Hoogendijk Peter M. C. Klein Klouwenberg Janneke Horn Marc J. Bonten Aeilko H. Zwinderman Olaf L. Cremer Marcus J. Schultz Tom van der Poll On behalf of the MARS Consortium Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: a propensity-matched analysis Received: 5 September 2015 Accepted: 29 November 2015 Published online: 14 January 2016  The Author(s) 2016. This article is published with open access at S A complete list of members of the MARS Consortium can be found in Acknowledgments section. Electronic supplementary material The online version of this article (doi:10.1007/s00134-015-4171-9) contains supplementary material, which is available to authorized users. M. A. Wiewel ())  S. F. de Stoppelaar  L. A. van Vught  A. J. Hoogendijk  T. van der Poll Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Room G2-130, 1105 AZ Amsterdam, The Netherlands e-mail: m.a.wiewel@amc.uva.nl Tel.: ?31-20-5665910 M. A. Wiewel  S. F. de Stoppelaar  L. A. van Vught  A. J. Hoogendijk  T. van der Poll The Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands J. F. Frencken  P. M. C. Klein Klouwenberg  O. L. Cremer Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, The Netherlands J. F. Frencken  P. M. C. Klein Klouwenberg  M. J. Bonten Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands P. M. C. Klein Klouwenberg  M. J. Bonten Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands J. Horn  M. J. Schultz Department of Intensive Care, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands A. H. Zwinderman Department of